The first month on either medication often involves adjustment symptoms, including nausea, reduced appetite that feels uncomfortable rather than liberating, and changes in digestive patterns
doi:10.1056/NEJMoa2028198 Nauck MA, Muus Ghorbani ML, Kreiner E, Saevereid HA, Buse JB
The results also underscore the limitations of current imaging methodologies and sample sizes, as the field still lacks high-quality, well-controlled magnetic resonance spectroscopy (MRS) studies that consistently assess glutathione in multiple brain areas
they are sudden food aversions driven by complex neurobiology
Recent studies suggest that GLP-1 drugs may also slow the progression of Parkinson's symptoms in humans and lower the risk of heart attack, stroke and cardiovascular death by approximately 20%
PMID 24131523